trending Market Intelligence /marketintelligence/en/news-insights/trending/-cu1R2BuePOhoX2Ugebv1Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

TransEnterix approves a planned reverse stock split at 1-for-13 ratio

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


TransEnterix approves a planned reverse stock split at 1-for-13 ratio

TransEnterix Inc. specified and approved a reverse stock split of its shares at a 1-for-13 ratio, effective Dec. 11.

Trading of the Morrisville, N.C.-based medical device company's shares will continue on a split-adjusted basis Dec. 12. The company will continue to trade on the New York Stock Exchange under the ticker TRXC post-split.

Following the reverse stock split, fractional shares will round up to a full share for the stockholders who hold them.